THE SINGLE LIFE
has never been better

Treat dogs to more than 4 weeks of otitis externa relief with a single in-clinic dose.

SEE DETAILS

Update your in-clinic otitis treatment to Mometamax Single™

The only single-dose treatment approved to treat Pseudomonas aeruginosa

In-clinic administration offers convenience, confidence, and built-in compliance

Triple-action formula includes proven antibacterial, antifungal, and anti-inflammatory ingredients

Unique combination of 3 trusted ingredients

Make Mometamax Single your first choice for in-clinic otitis treatment.

Superior triple-action formulation

See how one dose of Mometamax Single delivers the broadest spectrum of activity of all in-clinic otic treatments.

REVIEW THE INGREDIENTS

Relief that delivers on safety

Mometamax Single provides reliable efficacy in a single 0.8-mL dose with proven safety.

Well-tolerated¹

No ototoxicity seen¹

Normal lab results¹

No clinically relevant treatment-related findings were noted in blood work and urinalysis.*

No ototoxicity seen¹

No ototoxicity was seen when dosed up to 5x the labeled dose every 2 weeks for 3 doses.

* Dogs were administered a series of 3 doses of Mometamax Single (0.8 mL) at 2-week intervals for the study.

Reach for the single-dose solution that delivers reliable relief

The thrilling triple-action formula in Mometamax Single makes it the clear choice for in-clinic treatment of otitis externa.

Or, fill out this form to receive more information about Mometamax Single and how to order.

BUY NOW AT VETCOVE® MORE INFO

Important Safety Information

Mometamax Single is for otic use in dogs only. Do not use in cats. Mometamax Single should be administered by veterinary personnel. Do not use in dogs with known tympanic membrane perforation. The integrity of the tympanic membrane should be confirmed before administering the product. Reevaluate the dog if hearing loss or signs of vestibular dysfunction are observed during treatment. Do not use in dogs with known or suspected hypersensitivity to gentamicin, posaconazole, or mometasone furoate. Avoid contact with eyes. For complete instructions and safety information, refer to the product label.

References